NCT04439227 2025-10-31Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I)National Cancer Institute (NCI)Phase 2 Active not recruiting35 enrolled